NCT00533728View on ClinicalTrials.gov

Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

Soluble beta-glucan (SBG)

Trial Locations (1)

0310

Rikshospitalet, Kreftklinikken Radiumhospitalet, Oslo

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY

NCT00533728 - Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter